STCube

About Us
Nelmastobart
- Novel Immune-Checkpoint BTN1A1
- Main Indications
R&D
- Research Achievements
- Pipeline
IR
PR
- Press Release
- Notices
Careers
- Careers
Partnership
- Partnership

ENG

KOR
ENG

About Us
Nelmastobart
- Novel Immune-Checkpoint BTN1A1
- Main Indications
R&D
- Research Achievements
- Pipeline
IR
PR
- Press Release
- Notices
Careers
- Careers
Partnership
- Partnership

PR

STCube is dedicated to developing precision-driven immunotherapies,
bringing new hope to more cancer patients.

Press Release
Notices

Notices

Press Release
Notices

Notices

Home
PR
Notices

1

2201, Trade Center Trade Tower, 511 Yeongdong-daero, Gangnam-gu, Seoul, Republic of Korea

Tel : +82-2-551-3370

Copyright by STCube All Rights Reserved.